Global Dialysis Machine Market Size study & Forecast, by Hemodialysis (Conventional Hemodialysis, Short Daily Hemodialysis, Nocturnal Hemodialysis), Peritoneal Dialysis (Continuous Ambulatory Peritoneal Dialysis, Automated Peritoneal Dialysis), Equipment

Global Dialysis Machine Market Size study & Forecast, by Hemodialysis (Conventional Hemodialysis, Short Daily Hemodialysis, Nocturnal Hemodialysis), Peritoneal Dialysis (Continuous Ambulatory Peritoneal Dialysis, Automated Peritoneal Dialysis), Equipment (Dialysis Machines, Water Treatment Systems, Others), Consumables (Dialyzers, Catheters, Others), Disease Type (Chronic, Acute), End User (Hospitals, Clinics, Ambulatory Surgical Centers, Home Care Setting), and Regional Analysis, 2023-2030

Global Dialysis Machine Market is valued approximately USD 16893.13 Million in 2022 and is anticipated to grow with a healthy growth rate of more than 4.6% over the forecast period 2023-2030. Dialysis is a vital procedure utilized to eliminate waste substances such as urea and creatinine from the bloodstream in individuals with compromised kidney function, typically those suffering from chronic renal failure. This process is essential in the treatment of end-stage renal disease (ESRD) and as a preparatory step for kidney transplantation. Dialysis is crucial in restoring electrolyte balance, purifying the blood, and eliminating excess fluid and toxins from the body. Hemodialysis and peritoneal dialysis are the two primary methods employed for dialysis. Hemodialysis involves the extracorporeal removal of waste substances like urea from the patient's blood, while peritoneal dialysis utilizes the peritoneum in the abdomen for dialysis. The market growth is driven by key factors such as the increasing prevalence of chronic kidney disease, the growing aging population, and the development and expansion of healthcare infrastructure.

The rising incidence of chronic kidney disease (CKD) serves as a key catalyst for the expansion of the dialysis machines market. CKD, a progressive condition often asymptomatic in its early stages, impacts a substantial number of individuals worldwide. Multiple factors contribute to the escalating burden of CKD, including the increasing prevalence of conditions like diabetes and hypertension. As per Statista, in 2021, the prevalence of end-stage renal disease (ESRD) reached approximately 2,219 cases per one million population, marking a significant rise from the rate of 1,644 per one million population observed in 2001. This statistic illustrates the trajectory of prevalent ESRD cases in the U.S. from 2000 to 2021. Furthermore, in the United States, chronic kidney disease (CKD) is marginally more prevalent among females than males, with 15.4 percent of females diagnosed with CKD during the period from 2017 to 2020, in contrast to 12.6 percent of males. Additionally, CKD is more commonly observed in older individuals, with the majority of cases occurring among those aged 65 years and older. However, limited access to dialysis services, and high cost associated with dialysis treatment stifle market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Dialysis Machine Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America is leading the regional growth of dialysis machines market, both in terms of market share and revenue, throughout the forecast period from 2023 to 2030. This dominance is attributed to the region's heightened investment in research and development capabilities, expanding government initiatives, and enhanced healthcare infrastructure across various countries. Meanwhile, the Asia-Pacific region is projected to witness the highest growth rate in the dialysis machines market during the forecast period from 2023 to 2030. This growth is fueled by increased government expenditure on the healthcare sector, advancements in technology, and government-led initiatives aimed at enhancing healthcare accessibility and quality.

Major market player included in this report are:
Diaverum (Sweden)
Baxter (U.S.)
B. Melsungen AG (Germany)
BD (U.S.)
Cantel Medical (U.S.)
DaVita Inc. (U.S)
Dialife (Switzerland)
Fresenius Medical Care AG & Co. KGaA (Germany)
Isopure Corp. (U.S.)
Medtronic (Ireland)

Recent Developments in the Market:
 In November 2021, Fresenius Medical Care unveiled innovative digitalized solutions aimed at empowering patients with end-stage kidney disease to undergo dialysis conveniently from their residences. These offerings include the 5008S hemodialysis (HD) machine and a novel automated peritoneal dialysis (APD) machine.

Global Dialysis Machine Market Report Scope:
 Historical Data – 2020 - 2021
 Base Year for Estimation – 2022
 Forecast period - 2023-2030
 Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
 Segments Covered – Haemodialysis, Peritoneal Dialysis, Equipment, Consumable, Disease Type, End-Users, Region
 Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:

By Hemodialysis:
Conventional Hemodialysis
Short Daily Hemodialysis
Nocturnal Hemodialysis
By Peritoneal Dialysis:
Continuous Ambulatory Peritoneal Dialysis
Automated Peritoneal Dialysis
By Equipment:
Dialysis Machines
Water Treatment Systems
Others
By Consumables:
Dialyzers
Catheters
Others
Disease Type:
Chronic
Acute
By End User:
Hospitals
Clinics
Ambulatory Surgical Centers
Home Care Setting
By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.